| Jessica Lynn Fetzer, PHARMD | |
|
3101 N 11th St Ste 2, Bismarck, ND 58503-0594 | |
| (701) 224-9521 | |
| (701) 224-1360 |
| Full Name | Jessica Lynn Fetzer |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3101 N 11th St Ste 2, Bismarck, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922617968 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH6232 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Lynn Fetzer, PHARMD 3511 21st St Se Apt 104, Mandan, ND 58554-1396 Ph: (701) 204-7903 | Jessica Lynn Fetzer, PHARMD 3101 N 11th St Ste 2, Bismarck, ND 58503-0594 Ph: (701) 224-9521 |
News Archive
The new Childhood and Adolescent Immunization Schedule and the Adult Immunization Schedule for 2020 are out, just released by the Advisory Committee on Immunization Practices (ACIP). This is an annual event following its yearly revision.
Waters Corporation reported fourth quarter 2009 sales of $429 million, an increase of 3% from sales of $418 million in the fourth quarter of 2008. In the quarter, foreign currency translation increased sales growth rate by 4% and on a currency neutral basis, sales decreased by 1% in comparison to the prior year's fourth quarter sales. On a GAAP basis, earnings per diluted share (E.P.S.) for the fourth quarter were $1.08, compared to $1.01 for the fourth quarter of 2008. On a non-GAAP basis, including the adjustments in the attached reconciliation, E.P.S. grew 5% to $1.12 from $1.07 in the fourth quarter of 2008.
A novel cancer-promoting molecular mechanism has been discovered by Pierluigi Scalia, M.D., Ph.D., with his co-workers at the Sbarro Institute for Cancer Research and Molecular Medicine, Division of Biology, Temple University, the Department of Medical Biotechnologies at University of Siena, Italy and the Italian non-profit research organization ISOPROG, in collaboration with the Center of Biocomputational Sciences, part of the College of Science and Technology in Philadelphia.
The Austrian Breast & Colorectal Cancer Study Group, Alliance Foundation Trials, the Breast International Group, PrECOG, LLC, the German Breast Group, and the NSABP Foundation today announced that the independent Data Monitoring Committee for the global Phase 3 early breast cancer PALbociclib CoLlaborative Adjuvant Study trial determined that the study is unlikely to show a statistically significant improvement in the primary endpoint of invasive disease-free survival following a preplanned interim analysis.
› Verified 2 days ago
Ms. Kristy Susanne Vadnais, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: St. Alexius Medical Center, 900 E. Broadway Ave., Bismarck, ND 58501 Phone: 701-530-6900 Fax: 701-530-6940 | |
Dr. Michelle Rae Carson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-6186 | |
Dr. Ashley Norton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3124 Colorado Ln Ste 400, Bismarck, ND 58503 Phone: 701-223-5750 Fax: 877-790-2139 | |
Charlene Sampson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Rosser Ave, Bismarck, ND 58501 Phone: 701-530-6311 Fax: 701-530-6317 | |
Mrs. Tamara Ruggles, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 303 N 4th St, Bismarck, ND 58501 Phone: 701-223-2424 | |
Brennen Kuntz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3103 Yorktown Dr, Bismarck, ND 58503 Phone: 701-425-0789 | |
Dr. Lucas V Hoechst, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 N 9th St, Bismarck, ND 58501 Phone: 701-530-6050 |